Silexion Therapeutics shares rose 11% in Friday's after-market session. The roundup gives no business news that changes its outlook.
A share-price move shows how trading went, not whether Silexion's business changed. The article gives no new results, plans, or other company update. So it does not change the company's outlook.
Lexaria Bioscience shares rose 10% in Friday's after-market session. The roundup gives no business news that changes its outlook.
Trinity Biotech shares rose 8.4% in Friday's after-market session. The roundup gives no business news that changes its outlook.
Aldeyra Therapeutics shares rose 7.6% in Friday's after-market session. The roundup gives no business news that changes its outlook.
Genprex shares rose 7.1% in Friday's after-market session. The roundup gives no business news that changes its outlook.
Humacyte shares rose 6.8% in Friday's after-market session. The roundup gives no business news that changes its outlook.
Follow Silexion Therapeutics (SLXN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SLXN